In recent years, both the actual number of overweight/obese individuals and their proportion of the population have steadily been rising worldwide and obesityrelated diseases have become major health concerns. In addition, as obesity is associated with an increased incidence of gastroenterological cancer, the number of obese patients has also been increasing in the field of gastroenterological surgery.
| INTRODUCTION
The overweight/obese population has been steadily increasing worldwide. According to the WHO, with 1.3 billion overweight (25 < body mass index [BMI] < 30) people and 600 million obese (BMI > 30) people in the world, 1 the obesity rate exceeds 10% for both genders and has more than doubled during the past 40 years. 2 Furthermore, as seven of the top 10 causes of death/physical disability are chronic disorders such as cancer and diabetes, which are closely related to obesity, 3 it can be said that obesity is among the world's major health concerns at present. According to "Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective" by the World Cancer Research Fund and American Cancer Society, gastroenterological cancer is known to be closely related to obesity as, in obese patients, the incidences of esophageal adenocarcinoma, colorectal cancer, and pancreatic cancer are clearly increased, while there is also a strong association with gallbladder cancer, and a possible association with liver cancer. 4 In contrast, there are a number of reports describing the influences of obesity on gastroenterological surgery worldwide. However, the results are often difficult to pool because of differences among surgical procedures, surgical approaches, complications associated with specific organs/surgical methods, and obesity classifications. In addition, the events evaluated, such as short-term outcomes (eg complications), long-term outcomes (eg overall survival), and surgical outcomes (eg operative time, hemorrhage volume), often vary markedly among studies. The present review aims to provide an overview of how obesity affects gastroenterological
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surgery based on the recent literature. For this review, we organized recently reported surgical procedures according to anatomical/surgical techniques as the influences of obesity on surgery might differ among organs or surgical procedures.
| GENERAL REMARKS: OBESITY PARADOX
Regarding gastroenterological cancer surgery, Shimada et al, 5 conducting a systematic review, noted high BMI to be associated with postoperative morbidity rate, but not with poor oncological outcomes, whereas low BMI was significantly associated with inferior oncological outcomes. Mullen et al 6 obtained similar results in a large-scale review, showing the complication rate to be higher in obese than in normal weight patients, whereas 30-day mortality was lower for overweight and obese patients than for those of normal weight, undergoing general surgeries other than vascular and bariatric operations (n = 118 707). According to the literature, BMI < 18.5 (underweight) is associated with particularly high rates of both complications and death.
As mentioned previously, the phenomenon wherein obesity provides an advantage against postoperative mortality is called the "Obesity paradox" and has been extensively described. In 2258 cases undergoing gastroenterological surgery (eg esophagectomy, gastrectomy, hepatectomy, pancreatectomy, low anterior resection (LAR)/ proctectomy), morbidity was higher in those with BMI > 30, but mortality was still significantly better in this group than in the patients with normal BMI undergoing the same procedures. 7 In contrast, mortality was higher in patients with BMI < 18.5 or BMI > 40. 7 Benjamin et al 8 indicated that both morbidity and mortality were more favorable in the obese than in the normal weight group receiving emergency abdominal surgery. A similar obesity paradox was indicated, by organ, for colorectal cancer surgery 9, 10 and for gastric cancer surgery.
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This obesity paradox phenomenon has not, however, been confirmed for all surgical procedures in the field of gastroenterological surgery. A cross-sectional analysis of the influences of obesity on surgery, examining multiple organs/surgical procedures, by our research group, 12 indicated that operative time was prolonged as the BMI category rose for eight principal gastroenterological surgical procedures (n = 232 199) and mortality was also higher in patients with BMI > 30. Our prior study revealed that the overweight group tended to have the lowest mortality rate, an observation consistent with those made in cases undergoing colorectal cancer surgery/gastric cancer surgery. This was attributed to Asian populations having a higher percentage of body fat and a greater risk of obesity-related comorbidities as compared to non-Asians with similar BMI. 13 By contrast, this phenomenon was not recognized in patients undergoing hepatectomy or pancreaticoduodenectomy (PD). In addition, Anazawa et al 14 examined a risk model of 30-day mortality for three gastroenterological surgery procedures (right hemicolectomy, LAR, PD) using a database from Japan and the USA. However, as mortality is significantly higher with LAR and PD for patients with BMI > 30 in Japan and the USA, respectively, the influences of obesity may vary not only among surgical procedures but also according to race.
| ESOPH AGEAL CANCER SURGERY
The incidence of esophageal cancer is particularly high in the area from the east coast of the Caspian Sea to Northeast China via Central Asia, the so-called Asian belt, and this cancer tends to be squamous cell carcinoma (SCC). 15 In contrast, esophageal adenocarcinoma is frequently found in Western countries such as the UK/USA and the frequency has been increasing in recent years. 16 Furthermore, the WHO concluded that the esophageal adenocarcinoma risk is clearly increased by obesity. As mentioned above, the characteristics of esophageal cancer differ markedly depending on histological features, allowing discrimination from other gastrointestinal malignant tumors. Thus, the influence of obesity on esophageal surgery should also be examined by focusing on histological type.
In examinations of the influences of obesity on esophageal surgery, the survival rate is often used as perioperative mortality is high compared to other gastrointestinal surgeries. As previously described in the systematic review by Shimada et al, 5 it is often reported that outcomes are improved by high BMI and are, at least, not worsened by high BMI, according to meta-analyses. [17] [18] [19] [20] Furthermore, the influences of obesity on outcomes might reportedly differ depending on histological differences between adenocarcinoma or SCC. 17, 21 In contrast, a number of studies focusing on the survival rate of underweight patients have demonstrated unfavorable outcomes. 18, 22, 23 The reasons for obesity influencing outcomes may differ depending on whether BMI is high or low, in association with certain oncological background factors, such as tumor invasion which tends to be more aggressive in the underweight. 18, 24 
| GASTRIC CANCER SURGERY
East Asia is the source of several reviews on the influences of obesity on gastric cancer surgery, reflecting the high morbidity associated with this cancer in the region.
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Chen et al 11 reported an obesity paradox wherein overall survival was significantly better in patients with BMI > 25 than in those with normal BMI. Nonetheless, other than the aforementioned report,
many studies failed to demonstrate any influence of obesity on longterm survival. [28] [29] [30] [31] By contrast, Struecker et al 28 The conclusion has often been reached, based on relatively large-scale reports, that obesity negatively influences the postoperative complication rate. This negative influence might account for the high risks of complications such as incision infection, leakage, postoperative pneumonia, and intra-abdominal abscess. [30] [31] [32] In contrast, although BMI routinely serves as an obesity index, the visceral fat area (VFA) is reportedly a more appropriate predictor of complications. 33, 34 Notably, VFA is often used as an obesity index for patients developing pancreatic fistula as a specific complication after gastrectomy, and an increase in VFA can serve as an important indicator of pancreatic fluid leakage risk. [34] [35] [36] Reviews limited to laparoscopic surgery noted that obesity may prolong the operative time, without influencing either the complication rate or the survival rate. 37, 38 These reviews suggest the safety and effectiveness of highly difficult laparoscopic surgery as compared to laparotomy. In addition, robotic surgery for gastric cancer has recently been conducted as a form of advanced medical care.
Only a few studies have shown the superiority of robotic surgery in obese cases, but robotic surgery may not outperform laparoscopic surgery, in terms of complications. Furthermore, operative time is prolonged with robotic surgery as compared to laparoscopic surgery. 39, 40 Table 2 shows a summary of past studies on the effects of obesity on outcomes of gastric cancer surgery.
| COLORECTAL SURGERY
More reviews of the impact of obesity on surgery have focused on the colon than any other organ. From an oncological viewpoint, obesity is widely regarded as being related to the morbidity of colorectal cancer.
As described previously, postoperative morbidity appears to be increased by obesity in patients undergoing colon surgery. However, the obesity paradox phenomenon is reflected by the mildly obese having the lowest operative mortality, whereas the highest operative mortality is associated with extreme obesity. 50 Moreover, obesity might reportedly be an independent risk factor for leakage. 51, 52 A meta-analysis (n = 4550) of laparoscopic surgery by Fung et al 53 found that, for colorectal cancer surgery, SSI, leakage, morbidity, and conversion rate are significantly higher in patients with BMI > 30 than in those with normal BMI. BMI, body mass index; DG, distal gastrectomy; GC, gastric cancer; LADG, laparoscopy-assisted distal gastrectomy; LDG, laparoscopic distal gastrectomy;
LG, laparoscopic gastrectomy; PG, proximal gastrectomy; RG, robotic gastrectomy; SSI, surgical site infection; TG, total gastrectomy; VFA, visceral fat area.
diseases studied are hepatocellular carcinoma and liver metastasis of colorectal cancer, but there are reviews actually targeting all hepatic disorders. [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] Table 4 shows a summary of past studies on the effects of obesity on outcomes of liver surgery. Our group conducted a large-scale review to examine the impacts of obesity on hepatic resection and found that obesity (BMI > 30) prolonged operative time by approximately 50 min as compared to surgery on non-obese patients undergoing hepatectomy of more than one segment apart from the lateral segment (n = 14 903). 12 In addition, Yokoo et al 57 , studying a similar surgical group, reported BMI > 30 to potentially be a risk factor for blood transfusion and BMI > 35 to be a risk factor for unplanned intubation (n = 14 970). In a similar report, Langella et al 58 noted that resection time, blood loss, and rate of pulmonary complications tended to rise if BMI > 30, and that obesity may negatively influence all three of these factors. In another large-scale review, Mathur et al 59 found that obese patients had significantly higher odds of having a complication than normal-weight patients (n=3960). However, because obesity may reportedly not influence postoperative complications in some cases, it is hoped that such cases can be analyzed in a future meta-analysis. [60] [61] [62] [63] Examining the influence of obesity on mortality, Kenjo et al As to the influence of obesity on liver transplantation recipients, Saab et al 65 conducted a meta-analysis (n = 74 487) showing that BMI does not influence either mortality or survival. However, obese patients had poorer survival in subgroup analyses of studies whose cohorts of obese and non-obese patients had similar causes of liver disease. 65 Furthermore, some studies have found that extreme obesity may increase mortality and worsen survival.
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T A B L E 3 Summary of past studies on the effects of obesity on outcomes of colorectal surgery 
| PANCREATIC SURGERY
In pancreatectomy including various procedures, obesity was defined as a risk factor for the occurrence of postoperative complications. 68, 69 Notably, several investigations have focused on pancreatic fistula after pancreatectomy, which is among the specific complications experienced. Ramsey and Martin 70 described pooled analyses, conducted as part of a meta-analysis, as showing a significant association between pancreatic fistula and BMI (n = 2736). Given these observations, increased BMI, which correlates with soft pancreatic consistency, a known risk factor for pancreatic fistula, might be among its causes. 71, 72 Obesity is frequently reported to exert no influence on operative mortality in patients with pancreatic malignancies, as is the case with surgeries on other organs. [68] [69] [70] In pancreaticoduodenectomy, numerous reviews have also consistently described obesity as exerting a negative influence. [73] [74] [75] [76] [77] Aoki et al 73 , applying a risk model (n = 17 564), suggested BMI > 25 to potentially be a factor predicting severe complications (Clavien Dindo Classification Grade 4 or higher) including pancreatic fistula (International Study Group Pancreatic Fistula Grade C). In addition, obesity has been identified as a risk factor for severe complications 74, 75 but not operative mortality. 76, 77 As with hepatectomy, obesity was found to be associated with increased intraoperative blood loss. 69, 75 Even with other surgical procedures, such as distal pancreatectomy and central pancreatectomy, obesity was also identified as a risk factor for complications. 78, 79 Table 5 shows a summary of past studies on the effects of obesity on outcomes of pancreatic surgery.
Pecorelli et al 76 reported VFA to be an independent risk factor for pancreatic fistula, similar to its influence as a risk factor for pancreatic fistula after gastrectomy. This suggests VFA to possibly be a more precise indicator than BMI in patients undergoing pancreatectomy because increased VFA may exert a direct effect making surgical techniques more complicated. In addition, Pecorelli et al 76 addressed the combination of visceral obesity and sarcopenia as the best predictor of postoperative death.
| CONCLUSION S
Obesity is generally considered to exert an adverse effect on major gastroenterological surgeries. In particular, obesity prolongs operative BMI, body mass index; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; Hx, hepatectomy of more than one segment other than the lateral segment.
time and may thus be a risk factor for short-term complications. However, obesity may not adversely influence long-term surgical outcomes.
The influences of obesity on surgery may vary depending on the surgical procedure, surgical outcome and/or racial differences in obesity.
Preoperative assessment with consideration of not only obesity but also other operative risks is essential for all surgical procedures.
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